MFDS
- Marketing authorisation holder: XCOVERY
- Status: likely_approved
🇰🇷 Ensacove in South Korea
Ensacove (ENSARTINIB) regulatory status in South Korea.
Marketing authorisation
Ensacove in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Ensacove approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Ensacove in South Korea?
XCOVERY holds the South Korean marketing authorisation.